Skip to main content

Comparative in vitro activity of the new glycopeptide SK&F 104662 against problematic gram-positive bacteria

European Journal of Clinical Microbiology and Infectious Diseases volume 10, pages 782–784 (1991)Cite this article

Abstract

The in vitro activity of the new glycopeptide antibotic SK&F 104662 against problematic gram-positive microorganisms was determined using the agar dilution technique. For comparison, ampicillin, oxacillin, vancomycin, erythromycin and gentamicin were tested. SK&F 104662 was found to have high activity againstStaphylococcus aureus, coagulase-negative staphylococci (both methicillin sensitive and resistant strains),Enterococcus faecalis, Enterococcus faecium, Listeria monocytogenes, Corynebacterium jeikeium andCorynebacterium group D2. All of 254 isolates, except one vancomycin-resistant strain ofEnterococcus faecium, were inhibited by 2 mg/l of SK&F 104662; this compound may thus be potentially useful in the treatment of infections with the above-mentioned gram-positive pathogens.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. Approved standard M7-A. NCCLS, Willanova, PA, 1985.

    Google Scholar 

  2. Coyle MB, Lipsky BA Coryneform bacteria in infectious diseases: clinical and laboratory aspects. Clinical Microbiology Reviews 1990, 3: 227–246.

    PubMed  Google Scholar 

  3. Soriano F, Fernández-Roblas R Infections caused by antibiotic-resistantCorynebacterium group D2. European Journal of Clinical Microbiology and Infectious Diseases 1988, 7: 337–341.

    Article  Google Scholar 

  4. Yao JDC, Eliopoulos GM, Moellering RC In vitro activity of SK&F 104662, a new glycopeptide antibiotic. Antimicrobial Agents and Chemotherapy 1989, 33: 965–967.

    PubMed  Google Scholar 

  5. Jorgensen JH, Redding JS, Maher LA Antibacterial activity of the new glycopeptide antibiotic SK&F 104662. Antimicrobial Agents and Chemotherapy 1989, 33: 560–561.

    PubMed  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Microbiology, Fundación Jiménez Diaz, Universidad Autónoma de Madrid, Avda. Reyes Católicos 2, 28040, Madrid, Spain

    F. Soriano, J. Zapardiel & R. Fernández-Roblas

Authors
  1. F. Soriano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Zapardiel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Fernández-Roblas
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Soriano, F., Zapardiel, J. & Fernández-Roblas, R. Comparative in vitro activity of the new glycopeptide SK&F 104662 against problematic gram-positive bacteria. Eur. J. Clin. Microbiol. Infect. Dis. 10, 782–784 (1991). https://doi.org/10.1007/BF01972511

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01972511

Keywords

  • Agar
  • Ampicillin
  • Vancomycin
  • Gentamicin
  • Erythromycin